Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
This organization files only for itself — no outside firm has reported fees for it.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: sumitomo-pharma-america-inc-formerly-sunovion-pharmaceuticals-inc.
›
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
CPT
6 filings
$2.1M on those filings
Taxation/Internal Revenue Code
TAX
1 filing
$310K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
Seniors Prescription Drug Relief Act
6 filingsthrough 2022
H.R. 5237118th CongressFentanyl Crisis Research and Evaluation Act5 filingsthrough 2024
S. 3427117th CongressNeuroscience Center of Excellence Act of 20215 filingsthrough 2022
H.R. 3116th CongressElijah E. Cummings Lower Drug Costs Now Act5 filingsthrough 2020
H.R. 3117th CongressElijah E. Cummings Lower Drug Costs Now Act4 filingsthrough 2021
H.R. 5376117th CongressAn act to provide for reconciliation pursuant to title II of S. Con. Res. 14.4 filingsthrough 2022
H.R. 4758118th CongressAccelerating Kids’ Access to Care Act3 filingsthrough 2024
H.R. 4895118th CongressLowering Drug Costs for American Families Act3 filingsthrough 2024
S. 1264118th CongressSMART Prices Act3 filingsthrough 2024
S. 2372118th CongressAccelerating Kids’ Access to Care Act3 filingsthrough 2024
S. 3427118th CongressOvertime Pay for Protective Services Act of 20233 filingsthrough 2023
H.Res. 1390118th CongressRecognizing the 50th anniversary of the Legal Services Corporation.2 filingsthrough 2023
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Anthony MagnettiSumitomo Pharma America, INC.(FORMERLY Sunovion Pharmaceuticals Inc.)19 filingsthrough 2015
Mark WandaSumitomo Pharma America, INC.(FORMERLY Sunovion Pharmaceuticals Inc.)12 filingsthrough 2010
Tim HermesSumitomo Pharma America, INC.(FORMERLY Sunovion Pharmaceuticals Inc.)6 filingsthrough 2008
Jason NeefSumitomo Pharma America, INC.(FORMERLY Sunovion Pharmaceuticals Inc.)1 filingthrough 2008
Jennifer StollSumitomo Pharma America, INC.(FORMERLY Sunovion Pharmaceuticals Inc.)1 filingthrough 2008
Covered positions · 2 of 9 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
